Lincomycin(LM) antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Lincomycin(LM) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to Antibiotics diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Lincomycin(LM)

OVA-Lincomycin(LM)

Anti-Lincomycin(LM) mouse monoclonal antibody

Anti-Lincomycin(LM) human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

. Lincomycin (LM) in Veterinary Medicine:

Lincomycin, commonly referred to as LM, belongs to the lincosamide class of antibiotics and plays a crucial role in the field of veterinary medicine. With its distinct molecular structure, LM has garnered attention for its efficacy in combating various bacterial infections in multiple animal species, including poultry, swine, and cattle. The bacteriostatic action of LM is particularly valuable in treating infections caused by Gram-positive organisms such as Streptococcus, Staphylococcus, and Clostridium species. This broad-spectrum antibiotic is administered via various routes, including oral, intramuscular, and intravenous, depending on the specific needs of the animal and the severity of the infection.

Role in Veterinary Drug Residues and Additives (Serial Number 1):

The role of LM in veterinary drug residues and additives is critical in maintaining the integrity of the food supply chain and safeguarding public health. LM, when administered to animals, leaves residues in edible tissues such as muscle, milk, and eggs. Concerns arise regarding the potential impact of these residues on human health, including the development of antimicrobial resistance and the manifestation of adverse effects. The occurrence of antibiotic residues in animal-derived products has prompted stringent regulatory measures to monitor and control the presence of LM, ensuring compliance with acceptable limits for human consumption. Moreover, assessing the levels of LM residues is crucial for evaluating the adherence to withdrawal periods before animals can enter the food chain, preventing the presence of unsafe residues in consumable commodities.

2. Significance of Measuring Lincomycin (LM) (Serial Number 2):

The accurate measurement of Lincomycin (LM) levels is of paramount importance in various scientific, regulatory, and health-related contexts. Robust monitoring of LM levels in animal tissues and products is essential to comply with rigorous food safety regulations and standards. This process is instrumental in ensuring the absence of harmful residues in food products, mitigating potential health risks for consumers. Excessive residues of LM pose a significant threat to human health, contributing to the development of antimicrobial resistance, a growing concern within the global health community. The precise measurement of LM is instrumental in understanding and managing the development of antibiotic resistance, guiding the formulation of appropriate intervention strategies and policies to prevent its proliferation.

Furthermore, accurate quantification of LM contributes to the enhancement of veterinary pharmaceutical practices. By determining the optimal dosage and therapeutic efficacy of LM, veterinarians can ensure the successful treatment of bacterial infections in animals while minimizing the risk of adverse effects associated with excessive drug exposure. Additionally, the precise measurement of LM facilitates comprehensive research endeavors aimed at exploring the pharmacokinetics and pharmacodynamics of the drug, providing valuable insights into its mode of action, metabolism, and elimination from the animal body.

Moreover, the stringent measurement of LM levels supports regulatory oversight, enabling authorities to enforce compliance with established guidelines and standards for the use of antibiotics in veterinary medicine. This oversight is crucial for maintaining the safety and integrity of the food supply chain, preserving consumer confidence, and mitigating the potential risks associated with the consumption of animal-derived products. By implementing rigorous monitoring and measurement protocols, regulatory bodies can ensure the effective control of LM usage, preventing the emergence of drug-resistant bacteria and safeguarding animal and public health alike.

. Lincomycin (LM) in Veterinary Medicine:

Lincomycin, commonly referred to as LM, belongs to the lincosamide class of antibiotics and plays a crucial role in the field of veterinary medicine. With its distinct molecular structure, LM has garnered attention for its efficacy in combating various bacterial infections in multiple animal species, including poultry, swine, and cattle. The bacteriostatic action of LM is particularly valuable in treating infections caused by Gram-positive organisms such as Streptococcus, Staphylococcus, and Clostridium species. This broad-spectrum antibiotic is administered via various routes, including oral, intramuscular, and intravenous, depending on the specific needs of the animal and the severity of the infection.

Role in Veterinary Drug Residues and Additives (Serial Number 1):

The role of LM in veterinary drug residues and additives is critical in maintaining the integrity of the food supply chain and safeguarding public health. LM, when administered to animals, leaves residues in edible tissues such as muscle, milk, and eggs. Concerns arise regarding the potential impact of these residues on human health, including the development of antimicrobial resistance and the manifestation of adverse effects. The occurrence of antibiotic residues in animal-derived products has prompted stringent regulatory measures to monitor and control the presence of LM, ensuring compliance with acceptable limits for human consumption. Moreover, assessing the levels of LM residues is crucial for evaluating the adherence to withdrawal periods before animals can enter the food chain, preventing the presence of unsafe residues in consumable commodities.

2. Significance of Measuring Lincomycin (LM) (Serial Number 2):

The accurate measurement of Lincomycin (LM) levels is of paramount importance in various scientific, regulatory, and health-related contexts. Robust monitoring of LM levels in animal tissues and products is essential to comply with rigorous food safety regulations and standards. This process is instrumental in ensuring the absence of harmful residues in food products, mitigating potential health risks for consumers. Excessive residues of LM pose a significant threat to human health, contributing to the development of antimicrobial resistance, a growing concern within the global health community. The precise measurement of LM is instrumental in understanding and managing the development of antibiotic resistance, guiding the formulation of appropriate intervention strategies and policies to prevent its proliferation.

Furthermore, accurate quantification of LM contributes to the enhancement of veterinary pharmaceutical practices. By determining the optimal dosage and therapeutic efficacy of LM, veterinarians can ensure the successful treatment of bacterial infections in animals while minimizing the risk of adverse effects associated with excessive drug exposure. Additionally, the precise measurement of LM facilitates comprehensive research endeavors aimed at exploring the pharmacokinetics and pharmacodynamics of the drug, providing valuable insights into its mode of action, metabolism, and elimination from the animal body.

Moreover, the stringent measurement of LM levels supports regulatory oversight, enabling authorities to enforce compliance with established guidelines and standards for the use of antibiotics in veterinary medicine. This oversight is crucial for maintaining the safety and integrity of the food supply chain, preserving consumer confidence, and mitigating the potential risks associated with the consumption of animal-derived products. By implementing rigorous monitoring and measurement protocols, regulatory bodies can ensure the effective control of LM usage, preventing the emergence of drug-resistant bacteria and safeguarding animal and public health alike.

About GDU